Portfolio Companies News
April 27, 2018Wilson Therapeutics’ 2017 Annual ...
Apr 27, 2018 As of today, the 2017 Annual Report of Wilson Therapeutics AB (publ) is available as a pdf file on the company’s website www.wilsontherapeutics.com. Printed copies can be ordered by post to Wilson Therapeutics AB (publ), Kungsgatan 3, SE-111 43 Stockholm, Sweden, by telephone +... read more
April 26, 2018Strongbridge Biopharma plc to Host ...
DUBLIN, Ireland and TREVOSE, Pa., April 26, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that ... read more
April 24, 2018Targovax ASA: Invitation to first q...
Oslo, Norway, 24 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its first quarter 2018 results on Thursday, 3 May 2018. A presentation by Targovax's management to investors, analysts and the press ... read more
April 24, 2018Onxeo Announces Initiation of DRIIV...
First patient has been dosed with AsiDNA™, Company’s first-in-class DNA Repair Inhibitor Study approved in France and Belgium, and conducted in three internationally-renowned clinical centers Interim results expected in second half of 2018 Paris (France), April 24, 2018 – 06:00 pm... read more
April 23, 2018MIPS receives a positive decision i...
3:40 pm / April 23, 2018 MIPS AB (”MIPS”) has previously filed an opposition at the European Patent Office against European Patent 2,550,886 (the “Patent”), granted to Bauer Hockey Corp. (“Bauer”). The Patent relates to a sports helmet with rotational impact protection, based on a ... read more
February 07, 2018Q4 2017 General Market Overview
Since the start in 1996, HealthCap funds have invested in 110 portfolio companies.
41 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.